{"id":"https://openalex.org/W2060167539","doi":"https://doi.org/10.1002/ana.20592","title":"A\u03b242 immunization in Alzheimer's disease generates A\u03b2 N-terminal antibodies","display_name":"A\u03b242 immunization in Alzheimer's disease generates A\u03b2 N-terminal antibodies","alternate_titles":[],"publication_year":2005,"publication_date":"2005-09-01","ids":{"openalex":"https://openalex.org/W2060167539","doi":"https://doi.org/10.1002/ana.20592","mag":"2060167539","pmid":"https://pubmed.ncbi.nlm.nih.gov/16130106"},"language":"en","primary_location":{"id":"doi:10.1002/ana.20592","doi":"https://doi.org/10.1002/ana.20592","is_oa":false,"landing_page_url":"https://doi.org/10.1002/ana.20592","pdf_url":null,"source":{"id":"https://openalex.org/S114530997","display_name":"Annals of Neurology","issn_l":"0364-5134","issn":["0364-5134","1531-8249"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Neurology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2060167539"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Michael Lee","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michael Lee","raw_affiliation_strings":["Elan Pharmaceuticals, Inc., So. San Francisco, CA 94080, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Elan Pharmaceuticals, Inc., So. San Francisco, CA 94080, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068905100","display_name":"Fr\u00e9d\u00e9rique Bard","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267435","display_name":"Elan Pharmaceuticals, Inc. (Ireland)","ror":"https://ror.org/02s1xv184","country_code":"IE","type":"company","lineage":["https://openalex.org/I4405267435"]}],"countries":["IE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Frederique Bard","raw_affiliation_strings":["Elan Pharmaceuticals, Inc., So. San Francisco"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Elan Pharmaceuticals, Inc., So. San Francisco","institution_ids":["https://openalex.org/I4405267435"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083890601","display_name":"Kelly Johnson\u2010Wood","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267435","display_name":"Elan Pharmaceuticals, Inc. (Ireland)","ror":"https://ror.org/02s1xv184","country_code":"IE","type":"company","lineage":["https://openalex.org/I4405267435"]}],"countries":["IE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kelly Johnson-Wood","raw_affiliation_strings":["Elan Pharmaceuticals, Inc., So. San Francisco"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Elan Pharmaceuticals, Inc., So. San Francisco","institution_ids":["https://openalex.org/I4405267435"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014596895","display_name":"Celeste Lee","orcid":"https://orcid.org/0009-0001-6685-1401","observed_orcids":["https://orcid.org/0009-0001-6685-1401"]},"institutions":[{"id":"https://openalex.org/I4405267435","display_name":"Elan Pharmaceuticals, Inc. (Ireland)","ror":"https://ror.org/02s1xv184","country_code":"IE","type":"company","lineage":["https://openalex.org/I4405267435"]}],"countries":["IE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Celeste Lee","raw_affiliation_strings":["Elan Pharmaceuticals, Inc., So. San Francisco"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Elan Pharmaceuticals, Inc., So. San Francisco","institution_ids":["https://openalex.org/I4405267435"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079709388","display_name":"Kang Hu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267435","display_name":"Elan Pharmaceuticals, Inc. (Ireland)","ror":"https://ror.org/02s1xv184","country_code":"IE","type":"company","lineage":["https://openalex.org/I4405267435"]}],"countries":["IE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kang Hu","raw_affiliation_strings":["Elan Pharmaceuticals, Inc., So. San Francisco"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Elan Pharmaceuticals, Inc., So. San Francisco","institution_ids":["https://openalex.org/I4405267435"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015328792","display_name":"Sue G. Griffith","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sue G. Griffith","raw_affiliation_strings":["Elan Pharmaceuticals, Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Elan Pharmaceuticals, Inc., San Diego, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109165894","display_name":"Ronald S. Black","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4403928396","display_name":"Wyeth","ror":"https://ror.org/035j24j42","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4403928396"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ronald S. Black","raw_affiliation_strings":["Wyeth Research, Collegeville, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wyeth Research, Collegeville, PA","institution_ids":["https://openalex.org/I4403928396"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112062186","display_name":"Dale Schenk","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267435","display_name":"Elan Pharmaceuticals, Inc. (Ireland)","ror":"https://ror.org/02s1xv184","country_code":"IE","type":"company","lineage":["https://openalex.org/I4405267435"]}],"countries":["IE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Dale Schenk","raw_affiliation_strings":["Elan Pharmaceuticals, Inc., So. San Francisco"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Elan Pharmaceuticals, Inc., So. San Francisco","institution_ids":["https://openalex.org/I4405267435"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5062011413","display_name":"Peter A. Seubert","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267435","display_name":"Elan Pharmaceuticals, Inc. (Ireland)","ror":"https://ror.org/02s1xv184","country_code":"IE","type":"company","lineage":["https://openalex.org/I4405267435"]}],"countries":["IE"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Peter Seubert","raw_affiliation_strings":["Elan Pharmaceuticals, Inc., So. San Francisco"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Elan Pharmaceuticals, Inc., So. San Francisco","institution_ids":["https://openalex.org/I4405267435"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5062011413"],"corresponding_institution_ids":["https://openalex.org/I4405267435"],"apc_list":{"value":4700,"currency":"USD","value_usd":4700},"apc_paid":null,"fwci":3.3143,"has_fulltext":false,"cited_by_count":154,"citation_normalized_percentile":{"value":0.93133255,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"58","issue":"3","first_page":"430","last_page":"435"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11266","display_name":"Neuroinflammation and Neurodegeneration Mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9929999709129333},{"id":"https://openalex.org/keywords/amyloid-beta-1-42","display_name":"amyloid-beta 42","score":0.8579999804496765},{"id":"https://openalex.org/keywords/amyloid-plaques","display_name":"amyloid plaques","score":0.8930000066757202},{"id":"https://openalex.org/keywords/amyloid-precursor-protein","display_name":"amyloid precursor protein","score":0.8420000076293945},{"id":"https://openalex.org/keywords/meningoencephalitis","display_name":"meningoencephalitis","score":0.8389999866485596},{"id":"https://openalex.org/keywords/amyloid-plaque-clearance","display_name":"amyloid plaque clearance","score":0.6729999780654907}],"concepts":[{"id":"https://openalex.org/C2780801004","wikidata":"https://www.wikidata.org/wiki/Q1415366","display_name":"Immunization","level":3,"score":0.7660279870033264},{"id":"https://openalex.org/C2779664074","wikidata":"https://www.wikidata.org/wiki/Q3518405","display_name":"Terminal (telecommunication)","level":2,"score":0.6032794713973999},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.601132869720459},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5071237087249756},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5057134628295898},{"id":"https://openalex.org/C502032728","wikidata":"https://www.wikidata.org/wiki/Q11081","display_name":"Alzheimer's disease","level":3,"score":0.49364909529685974},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4224604368209839},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.37819623947143555},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.12132474780082703},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.09379681944847107},{"id":"https://openalex.org/C31258907","wikidata":"https://www.wikidata.org/wiki/Q1301371","display_name":"Computer network","level":1,"score":0.04943761229515076}],"mesh":[{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D000918","descriptor_name":"Antibody Specificity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000939","descriptor_name":"Epitopes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D004306","descriptor_name":"Dose-Response Relationship, Immunologic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007114","descriptor_name":"Immunization","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007114","descriptor_name":"Immunization","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D007150","descriptor_name":"Immunohistochemistry","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D008590","descriptor_name":"Meningoencephalitis","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008590","descriptor_name":"Meningoencephalitis","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D008590","descriptor_name":"Meningoencephalitis","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D010446","descriptor_name":"Peptide Fragments","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D010446","descriptor_name":"Peptide Fragments","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015153","descriptor_name":"Blotting, Western","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D016229","descriptor_name":"Amyloid beta-Peptides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D016229","descriptor_name":"Amyloid beta-Peptides","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D016229","descriptor_name":"Amyloid beta-Peptides","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018604","descriptor_name":"Epitope Mapping","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/ana.20592","doi":"https://doi.org/10.1002/ana.20592","is_oa":false,"landing_page_url":"https://doi.org/10.1002/ana.20592","pdf_url":null,"source":{"id":"https://openalex.org/S114530997","display_name":"Annals of Neurology","issn_l":"0364-5134","issn":["0364-5134","1531-8249"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Neurology","raw_type":"journal-article"},{"id":"pmid:16130106","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16130106","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of neurology","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":14,"referenced_works":["https://openalex.org/W1528113046","https://openalex.org/W1605023308","https://openalex.org/W1974256928","https://openalex.org/W1979415323","https://openalex.org/W1991989649","https://openalex.org/W1991993391","https://openalex.org/W2000917982","https://openalex.org/W2019274736","https://openalex.org/W2024262813","https://openalex.org/W2026156322","https://openalex.org/W2059861908","https://openalex.org/W2086278983","https://openalex.org/W2087763494","https://openalex.org/W2157064933"],"related_works":["https://openalex.org/W2059861908","https://openalex.org/W2152446053","https://openalex.org/W2000917982","https://openalex.org/W1546526125","https://openalex.org/W3022870261","https://openalex.org/W4232154259","https://openalex.org/W1980466604","https://openalex.org/W2970157750","https://openalex.org/W2945016564","https://openalex.org/W2040734764"],"abstract_inverted_index":{"Serum":[0],"samples":[1],"from":[2],"Alzheimer's":[3],"disease":[4],"(AD)":[5],"patients":[6,34],"immunized":[7],"with":[8],"Abeta42":[9],"(AN1792)":[10],"were":[11],"analyzed":[12],"to":[13,77,89,106],"determine":[14],"the":[15,46,72,92],"induced":[16],"antibody":[17],"properties":[18],"including":[19],"precise":[20],"amyloid-beta":[21],"peptide":[22],"(Abeta)":[23],"epitopes":[24],"and":[25,43,80,102],"amyloid":[26,55,99,113],"plaque-binding":[27],"characteristics.":[28],"The":[29,52],"predominant":[30],"response":[31],"in":[32,57,109,115],"these":[33],"is":[35,44,63],"independent":[36],"of":[37,50,54,97,112],"whether":[38],"or":[39,86],"not":[40,81,95],"meningoencephalitis":[41],"developed":[42],"against":[45],"free":[47],"amino":[48],"terminus":[49],"Abeta.":[51],"immunostaining":[53],"plaques":[56,114],"brain":[58],"tissue":[59],"by":[60,65],"patient":[61],"sera":[62],"adsorbable":[64],"a":[66],"linear":[67],"Abeta1-8":[68],"peptide,":[69],"demonstrating":[70],"that":[71],"antibodies":[73,93],"are":[74,94],"directed":[75],"predominantly":[76],"this":[78],"epitope":[79],"dependent":[82],"on":[83],"Abeta":[84],"conformations":[85],"aggregates":[87],"specific":[88],"plaques.":[90],"Furthermore,":[91],"capable":[96],"binding":[98],"precursor":[100],"protein":[101],"would":[103],"be":[104,107],"predicted":[105],"competent":[108],"facilitating":[110],"clearance":[111],"AD":[116],"brains.":[117]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2060167539","counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":16},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":10},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":9}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
